BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34883290)

  • 1. A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
    Li SS; Zhang CM; Wu JD; Liu C; Liu ZP
    Eur J Med Chem; 2022 Jan; 228():114037. PubMed ID: 34883290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
    Li T; Yu P; Chen Y; Sun B; Dong P; Zhu T; Meng X
    Eur J Med Chem; 2021 Oct; 222():113605. PubMed ID: 34126457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel mono- and bivalent ASGP-R-targeted drug-conjugates.
    Petrov RA; Maklakova SY; Ivanenkov YA; Petrov SA; Sergeeva OV; Yamansarov EY; Saltykova IV; Kireev II; Alieva IB; Deyneka EV; Sofronova AA; Aladinskaia AV; Trofimenko AV; Yamidanov RS; Kovalev SV; Kotelianski VE; Zatsepin TS; Beloglazkina EK; Majouga AG
    Bioorg Med Chem Lett; 2018 Feb; 28(3):382-387. PubMed ID: 29269214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo.
    Yu XQ; Yan QL; Shen S; Cheng ZY; Huang XX; Yao GD; Song SJ
    Bioorg Chem; 2022 Feb; 119():105509. PubMed ID: 34844768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
    Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
    J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Antitumor Effects of Britanin on Hepatocellular Carcinoma Cells and its Real-Time Evaluation by In Vivo Bioluminescence Imaging.
    Li H; Du G; Yang L; Pang L; Zhan Y
    Anticancer Agents Med Chem; 2020; 20(9):1147-1156. PubMed ID: 32106805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
    Li P; Liu Y; He Q
    Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma.
    Jiang S; Li M; Hu Y; Zhang Z; Lv H
    Carbohydr Polym; 2018 Oct; 197():194-203. PubMed ID: 30007605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
    Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
    Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
    [No Abstract]   [Full Text] [Related]  

  • 11. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.
    Pranatharthiharan S; Patel MD; Malshe VC; Pujari V; Gorakshakar A; Madkaikar M; Ghosh K; Devarajan PV
    Drug Deliv; 2017 Nov; 24(1):20-29. PubMed ID: 28155331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma.
    Yin Y; Guo J; Teng F; Yu L; Jiang Y; Xie K; Jiang M; Fang J
    Drug Des Devel Ther; 2019; 13():4173-4184. PubMed ID: 31849449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.
    Bian Y; Guo D
    Drug Des Devel Ther; 2020; 14():647-659. PubMed ID: 32109990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma.
    Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y
    Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of apigenin and paclitaxel.
    Li K; Li M; Luo Z; Mao Y; Yu Y; He Y; Zhou J; Fei Y; Pei Y; Cai K
    Biochem Biophys Res Commun; 2020 May; 526(2):321-327. PubMed ID: 32220496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response Surface Methodology to Optimize the Combination Treatment of Paclitaxel, Bufalin and Cinobufagin for Hepatoma Therapy.
    Zhang J; Shu C; Yi X; Zhu J; Lian X; Wu Y
    Comb Chem High Throughput Screen; 2021; 24(10):1727-1735. PubMed ID: 33172373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
    Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
    Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
    Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.